Trial
NCT02396433
Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
—
Condition
Cancer of the Breast
Intervention
Carboplatin
Why stopped
lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-08-25